[{"address1": "IDA Business Park", "city": "Bray", "zip": "A98 H5C8", "country": "Ireland", "phone": "353 1 276 9800", "fax": "353 1 276 9888", "website": "https://www.trinitybiotech.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.", "fullTimeEmployees": 380, "companyOfficers": [{"maxAge": 1, "name": "Mr. John  Gillard", "age": 43, "title": "President, CEO, Company Secretary & Director", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 710000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ronan  O'Caoimh A.C.A.", "age": 68, "title": "Founder, Director & Executive Advisor", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 80000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James  Walsh Ph.D.", "age": 66, "title": "Executive Director of Business Development & Executive Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 50000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Louise  Tallon", "title": "CFO & Chief Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jacqueline  O'Neill", "age": 51, "title": "Director of Operations", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary  Keating Ph.D.", "age": 51, "title": "Chief Technology Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eibhlin  Kelly", "age": 40, "title": "Chief Information Officer", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Colm  Molloy", "age": 53, "title": "Group Director of Human Resources & Culture", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adrian  Donohue", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.trinitybiotech.com/InvestorRelations/Pages/Company%20Overview.aspx", "maxAge": 86400, "priceHint": 4, "previousClose": 0.775, "open": 0.7699, "dayLow": 0.7576, "dayHigh": 0.8178, "regularMarketPreviousClose": 0.775, "regularMarketOpen": 0.7699, "regularMarketDayLow": 0.7576, "regularMarketDayHigh": 0.8178, "exDividendDate": 1433462400, "fiveYearAvgDividendYield": 1.19, "beta": 1.03, "forwardPE": -0.84444445, "volume": 82429, "regularMarketVolume": 82429, "averageVolume": 2291511, "averageVolume10days": 285350, "averageDailyVolume10Day": 285350, "bid": 0.7173, "ask": 0.7987, "bidSize": 100, "askSize": 100, "marketCap": 20914592, "fiftyTwoWeekLow": 0.74, "fiftyTwoWeekHigh": 3.55, "priceToSalesTrailing12Months": 0.3537292, "fiftyDayAverage": 0.8836, "twoHundredDayAverage": 1.698, "currency": "USD", "enterpriseValue": 248758912, "profitMargins": -0.34390998, "floatShares": 179657342, "sharesOutstanding": 27519200, "sharesShort": 596795, "sharesShortPriorMonth": 29143, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0217, "heldPercentInsiders": 0.12542, "heldPercentInstitutions": 0.14544, "shortRatio": 0.1, "shortPercentOfFloat": 0.0272, "impliedSharesOutstanding": 7641510, "bookValue": -2.536, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -20331000, "trailingEps": -2.25, "forwardEps": -1.03, "lastSplitFactor": "1:5", "lastSplitDate": 1708646400, "enterpriseToRevenue": 4.207, "enterpriseToEbitda": -28.762, "52WeekChange": -0.70769227, "SandP52WeekChange": 0.22903383, "lastDividendValue": 1.1, "lastDividendDate": 1433462400, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "TRIB", "underlyingSymbol": "TRIB", "shortName": "Trinity Biotech plc", "longName": "Trinity Biotech plc", "firstTradeDateEpochUtc": 719674200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "f11095f5-a45d-3fd0-867a-c30f29ce8486", "messageBoardId": "finmb_397947", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.76, "recommendationKey": "none", "totalCash": 2840000, "totalCashPerShare": 0.014, "ebitda": -8649000, "totalDebt": 93715000, "quickRatio": 0.865, "currentRatio": 1.643, "totalRevenue": 59126000, "revenuePerShare": 6.497, "returnOnAssets": -0.08189, "grossProfits": 21131000, "freeCashflow": -8385625, "operatingCashflow": -7300000, "revenueGrowth": 0.032, "grossMargins": 0.35739, "ebitdaMargins": -0.14628, "operatingMargins": -0.14645, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]